Ledger.Open graph →
SEC Form D · Amendment · filed April 7, 2025

Epicore Biosystems, Inc

Offering
$35.0M
Sold
$25.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Kimberly Querrey · Cambridge, MADirectorJohn Wright · Cambridge, MAExecJeffrey J. Model · Cambridge, MAExecStephen Lee · Cambridge, MAExecJames J. Ryan · Cambridge, MAExecAlexander J. Aranyosi · Cambridge, MAExecWeihua J. Li · Cambridge, MAExecJohn Rogers · Cambridge, MADirectorLaura Lang · Cambridge, MADirectorRoozbeh Ghaffari · Cambridge, MAExec · DirectorJohn Wright · Cambridge, MAExecKimberly Querrey · Cambridge, MADirectorJames J. Ryan · Cambridge, MAExecJohn Rogers · Cambridge, MADirectorRoozbeh Ghaffari · Cambridge, MAExec · DirectorJeffrey J. Model · Cambridge, MAExecLaura Lang · Cambridge, MADirectorWeihua J. Li · Cambridge, MAExecAlexander J. Aranyosi · Cambridge, MAExecStephen Lee · Cambridge, MAExecJeremy M. Johnson · Garden Grove, CADirectorJeong W. Koo · Garden Grove, CAExecSeung H. Kang · Garden Grove, CADirectorCliff H. Sung · Garden Grove, CAExecJanette M. Mah · Garden Grove, CAExecDong I. Kim · Garden Grove, CADirectorRyan H. Shin · Garden Grove, CAExecJohann M. You · Garden Grove, CAExec · DirectorMichael Wanezek · Milwaukee, WIExecKelly S. Marshall · Dallas, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗